S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
NASDAQ:SPNS

Sapiens International (SPNS) Stock Forecast, Price & News

$28.67
+0.09 (+0.31%)
(As of 09/25/2023 ET)
Compare
Today's Range
$27.07
$28.71
50-Day Range
$26.03
$30.70
52-Week Range
$16.18
$30.81
Volume
165,453 shs
Average Volume
125,181 shs
Market Capitalization
$1.58 billion
P/E Ratio
28.11
Dividend Yield
1.81%
Price Target
$29.25

Sapiens International MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
2.0% Upside
$29.25 Price Target
Short Interest
Healthy
0.64% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
1.21mentions of Sapiens International in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
6.35%
From $1.26 to $1.34 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.12 out of 5 stars

Computer And Technology Sector

363rd out of 584 stocks

Prepackaged Software Industry

112th out of 199 stocks


SPNS stock logo

About Sapiens International (NASDAQ:SPNS) Stock

Sapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, the European Union, the United Kingdom, Israel, and internationally. It offers Sapiens CoreSuite and Sapiens IDITSuite for personal, commercial, and specialty lines; and Sapiens CoreSuite, Sapiens UnderwritingPro, Sapiens ApplicationPro, Sapiens IllustrationPro, and Sapiens ConsolidationMaster for life, pension, and annuities. The company also provides Sapiens DigitalSuite for customers, agents, brokers, risk managers, customer groups and third-party service providers; Sapiens ReinsuranceMaster and Sapiens ReinsurancePro reinsurance solutions; and Sapiens Platform, Sapiens CoreSuite, Sapiens PolicyPro, and Sapiens ClaimsPro, as well as Sapiens PolicyGo, and Sapiens ClaimsGo for workers' compensation. In addition, it offers financial and compliance solutions, which comprise Sapiens FinancialPro, Sapiens Financial GO, Sapiens StatementPro, Sapiens CheckPro, and Sapiens Reporting Tools; and Sapiens Decision, an enterprise-scale platform that enables institutions to centrally author, store, and manage various organizational business logics. Further, the company provides tailor-made solutions based on its Sapiens eMerge platform; and program delivery, business, and managed services. It markets and sells its products and services through direct and partner sales. The company was founded in 1982 and is headquartered in Holon, Israel.

SPNS Price History

SPNS Stock News Headlines

His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
Sapiens (SPNS) was upgraded to a Sell Rating at Barclays
Sapiens (SPNS) Q2 Earnings Meet Estimates
Sapiens Reports Second Quarter 2023 Financial Results
See More Headlines
Receive SPNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sapiens International and its competitors with MarketBeat's FREE daily newsletter.

SPNS Company Calendar

Last Earnings
8/02/2023
Ex-Dividend for 8/30 Dividend
8/15/2023
Dividend Payable
8/30/2023
Today
9/25/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
Application Software
Current Symbol
NASDAQ:SPNS
CUSIP
N7716A15
Employees
4,754
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$29.25
High Stock Price Forecast
$35.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+2.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

Net Income
$52.60 million
Pretax Margin
14.44%

Debt

Sales & Book Value

Annual Sales
$474.74 million
Cash Flow
$1.57 per share
Book Value
$7.31 per share

Miscellaneous

Free Float
46,318,000
Market Cap
$1.58 billion
Optionable
Optionable
Beta
1.21
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Roni Al-Dor (Age 62)
    Pres, CEO & Director
  • Mr. Roni Giladi (Age 52)
    Chief Financial Officer
  • Mr. Ilan Buganim
    Chief Technology & Information Officer
  • Ms. Yaffa Cohen-Ifrah
    Chief Marketing Officer & Head of Investor Relations
  • Ms. Osnat Segev-Harel (Age 61)
    Head of Corp. Devel.
  • Mr. Rodrigo Rueda
    Sales Director
  • Ms. Noa Brummer
    Chief HR Officer
  • Mr. Raj Ghuman
    Sr. VP of Bus. Devel. – EMEA & APAC
  • Ms. Hagit Ashkenazi
    Exec. VP & Head of Professional Services
  • Mr. Gary J. Sherne
    EVP & Chief Revenue Officer of North America













SPNS Stock - Frequently Asked Questions

Should I buy or sell Sapiens International stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sapiens International in the last twelve months. There are currently 2 sell ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SPNS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SPNS, but not buy additional shares or sell existing shares.
View SPNS analyst ratings
or view top-rated stocks.

What is Sapiens International's stock price forecast for 2023?

4 brokerages have issued 12 month price targets for Sapiens International's shares. Their SPNS share price forecasts range from $20.00 to $35.00. On average, they predict the company's share price to reach $29.25 in the next twelve months. This suggests a possible upside of 2.0% from the stock's current price.
View analysts price targets for SPNS
or view top-rated stocks among Wall Street analysts.

How have SPNS shares performed in 2023?

Sapiens International's stock was trading at $18.48 at the beginning of 2023. Since then, SPNS stock has increased by 55.1% and is now trading at $28.67.
View the best growth stocks for 2023 here
.

Are investors shorting Sapiens International?

Sapiens International saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 193,400 shares, a decrease of 31.3% from the August 15th total of 281,600 shares. Based on an average trading volume of 150,700 shares, the days-to-cover ratio is presently 1.3 days. Currently, 0.6% of the shares of the stock are sold short.
View Sapiens International's Short Interest
.

When is Sapiens International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our SPNS earnings forecast
.

How were Sapiens International's earnings last quarter?

Sapiens International Co. (NASDAQ:SPNS) announced its earnings results on Wednesday, August, 2nd. The technology company reported $0.31 EPS for the quarter, meeting analysts' consensus estimates of $0.31. The technology company earned $128.30 million during the quarter, compared to analyst estimates of $126.79 million. Sapiens International had a net margin of 11.47% and a trailing twelve-month return on equity of 16.72%.

How often does Sapiens International pay dividends? What is the dividend yield for Sapiens International?

Sapiens International declared a Semi-Annual dividend on Wednesday, August 2nd. Stockholders of record on Wednesday, August 16th will be given a dividend of $0.26 per share on Wednesday, August 30th. This represents a dividend yield of 1.6%. The ex-dividend date is Tuesday, August 15th. This is a boost from the stock's previous Semi-Annual dividend of $0.23.
Read our dividend analysis for SPNS
.

What ETFs hold Sapiens International's stock?
Is Sapiens International a good dividend stock?

Sapiens International (NASDAQ:SPNS) pays an annual dividend of $0.52 per share and currently has a dividend yield of 1.82%. The dividend payout ratio is 50.98%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SPNS will have a dividend payout ratio of 38.81% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SPNS.

What guidance has Sapiens International issued on next quarter's earnings?

Sapiens International issued an update on its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $511.00 million-$516.00 million, compared to the consensus revenue estimate of $510.57 million.

What is Roni Al-Dor's approval rating as Sapiens International's CEO?

152 employees have rated Sapiens International Chief Executive Officer Roni Al-Dor on Glassdoor.com. Roni Al-Dor has an approval rating of 83% among the company's employees.

What other stocks do shareholders of Sapiens International own?
What is Sapiens International's stock symbol?

Sapiens International trades on the NASDAQ under the ticker symbol "SPNS."

Who are Sapiens International's major shareholders?

Sapiens International's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (2.74%), Royce & Associates LP (1.71%), Dimensional Fund Advisors LP (1.57%), Clal Insurance Enterprises Holdings Ltd (1.05%), State Street Corp (0.95%) and Renaissance Technologies LLC (0.93%).

How do I buy shares of Sapiens International?

Shares of SPNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sapiens International's stock price today?

One share of SPNS stock can currently be purchased for approximately $28.67.

How much money does Sapiens International make?

Sapiens International (NASDAQ:SPNS) has a market capitalization of $1.58 billion and generates $474.74 million in revenue each year. The technology company earns $52.60 million in net income (profit) each year or $1.02 on an earnings per share basis.

How many employees does Sapiens International have?

The company employs 4,754 workers across the globe.

How can I contact Sapiens International?

Sapiens International's mailing address is Azrieli Center 26 Harukmim St., Holon L3, 5885800. The official website for the company is www.sapiens.com. The technology company can be reached via phone at (723) 790-2000, via email at yaffa.cohen-ifrah@sapiens.com, or via fax at 972-3790-2942.

This page (NASDAQ:SPNS) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -